Skip to main content

Chapel Hill startup targets seed funding after working to diversify Novavax Covid-19 vaccine trial

A Chapel Hill startup with UNC ties is looking to raise cash to grow its headcount as it aims to help clinical trials become more diverse.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.